Bayer Agrees to Halt Ads for Aleve

Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.

NEW YORK Bayer Healthcare has agreed to stop all advertising for its over-the-counter analgesic Aleve that carries the tagline “Prescription strength relief without a prescription.”

The decision came following a recommendation by the National Advertising Division (NAD) of the Council of Better Business Bureaus. The NAD had reviewed the ads after a complaint was brought by rival Wyeth Consumer Healthcare.

Bayer spent $55 million on ads for Aleve last year, per Nielsen Monitor-Plus. Omnicom Group’s BBDO in Chicago is the brand’s lead agency.

“Bayer





AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in